Dividend Watch: What is Convatec and Why is it Soaring?

Convatec shares have increased by over 20% over the last five days on better-than-expected growth projections.

Christopher Johnson 15 November, 2024 | 10:37AM
Facebook Twitter LinkedIn

 

 

Dividend payer Convatec raised its guidance for 2024 following better-than-expected revenue growth.

Organic revenue growth for the first 10 months of 2024 to the end of October reached 7.7%, beating prior expectations of growth of between 5% to 7%.

The medical company’s adjusted operating profit margins also jumped by 21.5%.

Convatec attributes its improved revenue growth to the diversity of its product portfolio, new product launches, and improved operational efficiency.

Divisions including its Advanced Wound Care and Continence Care are helping to drive growth in the business.

Year to date, Convatec stock is up 2.56% to £2.48 just shy of Morningstar’s Fair Value Estimate for the business at £2.71.

Convatec paid a half yearly dividend of 1.42p as of October 4 2024.


The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Christopher Johnson  is data journalist at Morningstar

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures